-
Verstappen wins chaotic Singapore sprint after Russell crashes
-
Proposed next EU budget cut back in search for deal
-
Kiss tells Wallabies to 'return fire' after first loss as coach
-
All Blacks learn from 'failed' Springboks series to punish Wallabies
-
Russian strikes kill 11 including 3 children: Ukrainian authorities
-
Marquez grabs MotoGP championship lead after Indonesia sprint chaos
-
Russian teenager Andreeva breezes into China Open final
-
All Blacks extend Eden Park streak with big win over Wallabies
-
Major earthquake hits Panama, injures at least 27
-
Marquez grabs MotoGP championship lead with Indonesia sprint win
-
India detains 'cockroach' leaders ahead of election protest
-
Schauffele closes in on leaders after 'weird' round in Japan
-
'No divisions, no borders', French astronaut says of seeing Earth
-
Medvedev through at Shanghai Masters in first match since disqualification
-
India's 'cockroach' movement chief detained ahead of major protest
-
Trump sows doubt on plan to livestream US military execution
-
Year later, Gaza ceasefire promises mostly unfulfilled
-
Hunger and malnutrition stalk Gazans, a year on from ceasefire
-
Taiwan's leader says increasing defence spending to 'deter war'
-
Fernandez trumps MotoGP championship duo to grab Indonesia pole
-
Major quake hits Panama, no deaths reported
-
October 7 scars push Israel's first-time voters to right
-
Hurricane Isaias makes landfall in Florida
-
India deploys police, restricts transport ahead of major protest
-
Brazil prosecutors sue Shell for $108 mn over deadly 2024 floods
-
Three Mexicans convicted in murders of Australian, US surfers
-
Major earthquake destroys buildings, roads in Panama
-
Powerful waves lash California coast as storm threatens more damage
-
Anthropic AI model sent fake murder tip to Philadelphia police
-
Trump hails Russia deal to release diesel as midterms loom
-
7.7-magnitude quake rocks Panama, triggers tsunami warning
-
Lyon blow chance to go top after loss at Lens
-
Prince Harry booed at English rugby match
-
Stocks rise as Trump says Russia to release diesel to world markets
-
Kiplimo and Feysa seek repeat Chicago Marathon wins
-
Wildfire smoke shuts schools in Amazon's biggest city
-
Fuellkrug halts Dortmund after late goal flurry
-
Turkey jails 2 journalists pending trial for fund crisis 'misinformation'
-
Injured Ravens quarterback Jackson ruled out of Falcons clash
-
Major earthquake rocks Panama, triggers tsunami warning
-
Brewers aim to take down two-time defending champion Dodgers in NLCS rematch
-
Indian jailed in France for leading sadist Nazi cult that tortured girls
-
Tsunami alert after major earthquake rocks Panama
-
'Iron Mike' Ditka hailed as 'gold standard' NFL legend
-
Outer bands of Hurricane Isaias lash US Gulf Coast
-
Flydubai co-pilot planned suicide attack on Tel Aviv airport: UAE prosecutor
-
Hope, Rutherford fire West Indies to record T20 chase of 250
-
Mike Ditka: Chicago Bears icon as player and coach
-
Farhan leads Pakistan to T20 win over Sri Lanka
-
Outrage over plan to livestream US military firing squad execution
Global IP Thought Leaders, Scholars, and Policymakers to Gather in Paris for "Competing for the Cure" Conference on Biopharmaceutical Ecosystems
PARIS, FR / ACCESS Newswire / September 28, 2026 / On October 29-30, 2026, the Berkeley Policy Institute's Eira Initiative will host a major international conference titled "Competing for the Cure: Intellectual Property, Innovation Policy, and Biopharmaceutical Ecosystems" at the Maison de l'Amérique Latine in Paris.
The two-day event will bring together top economists, legal scholars, industry leaders, and policy architects in the life sciences to present ground-breaking empirical and policy research on how intellectual property rights, pricing controls, artificial intelligence, and trade frameworks impact biopharmaceutical innovation worldwide.
The conference takes place at a critical juncture for the life sciences, addressing international trade developments, patent reforms, pricing policy, ecosystem competition, and the evolving role of IP assets across major biopharma markets - including Europe, China, India, Japan, and the United States.
High-Level Keynotes & Policy Fireside Chat
The conference program features keynote addresses by Mark Schankerman (London School of Economics) and Yann Ménière (Chief Economist, European Patent Office).
A headline Fireside Chat with Nicolas Petit (European University Institute), Kamil Kiljanski (European Commission), and Hon. Peter-Anthony Pappas (US International Trade Commission), moderated by Bowman Heiden (Gothenburg Univ. & UC Berkeley), will translate empirical findings into actionable policy strategies.
Key Conference Sessions & Featured Research:
- Day 1, Panel 1: IP Rights and Biopharmaceutical Ecosystem Design Features research on IP-backed collateral lending post-2022 ("The Great Biotech Reset") by Christine McDaniel (World Bank) and network mapping of pharma innovation systems by Angelos Stenimachitis (Univ. of Essex / Compass Lexecon), commented by Mark Schankerman (LSE).
- Day 1, Panel 2: Patent Term, Tax Incentives, and Biopharmaceutical Innovation Features findings on Supplementary Protection Certificate eligibility by Satyaki Chakravarty (Università Cattolica), Australian patent pendency dynamics by Gaétan de Rassenfosse (EPFL), and the impact of orphan drug tax credits by Simona Gamba (Univ. of Milan) and Laura Magazzini (Sant'Anna), commented by Margaret Kyle (Mines Paris - PSL, CEDP).
- Day 1, Panel 3: Reinvigorating European & Global Ecosystems Explores structural shifts beyond the "blockbuster" drug development model by Andrea Dugo & Oscar Guinea (ECIPE), open strategic health sovereignty by Timo Minssen & Gabriela Maria Lenarczyk (Univ. of Copenhagen), and foreign R&D burden-sharing in trade deals by Alden Abbott & Satya Marar (Mercatus Center), commented by David Bosco (Univ. Aix-Marseille).
- Day 1, Panel 4: Price Controls, Pricing Policy, and Biopharmaceutical Innovation Features analysis on European price controls by Duane Schulthess (Vital Transformation), international price control comparisons by Stephen Ezell & Sandra Barbosu (ITIF), and the impact of value-based pricing on drug development by Katharina Blankart (Bern Univ. of Applied Sciences), commented by Jamie Simpson (C4IP).
- Day 2, Panel 1: IP Rights and Global Biopharmaceutical Markets Examines pharmaceutical global value chains by Walter Park (American Univ.) and the development of the Indian pharma ecosystem by Chirantan Chatterjee (Univ. of Sussex) & Aniruddh Bhaskaran (Carnegie Mellon Univ.), commented by Nikolaus Thumm (OECD).
- Day 2, Panel 2: China's Biopharmaceutical Ecosystem: Policy Insights and Global Implications Analyzes Chinese IP and other reforms in biopharma by Can Huang (Zhejiang Univ.), Chinese IP policy evolution by Mark Cohen (UC Berkeley), and China's global biopharma rise by Dan Prud'homme (Florida Intl. Univ.) & Tao Bai (Univ. of Queensland), commented by Sharon Belenzon (Duke Univ.) and Jonathan Barnett (USC).
- Day 2, Panel 3: Artificial Intelligence, Pandemics, and Biopharmaceutical Drug Development Examines patent strategy considerations for AI drug discovery by Laura Fè (Murgitroyd) & Alice Norga, and the impact of public health outbreaks on innovation by Xixi Hu (UBC), commented by Jonathan Barnett (USC).
Event Details & Registration
- Dates: October 29-30, 2026
- Venue: Maison de l'Amérique Latine, 217 Bd Saint-Germain, 75007 Paris, France
- Format: In-Person Conference
- Registration Link: In-Person Conference Registration
To view the complete agenda, speaker line-up, and paper abstracts, please visit https://eirainitiative.org/events/
FOR MORE INFORMATION, CONTACT:
EIRA Initiative / Berkeley Policy Institute
Email: [email protected]
Website: https://eirainitiative.org/events/
SOURCE: EIRA Initiative
View the original press release on ACCESS Newswire
D.Cunningha--AMWN